RadioMedix, Inc.
RadioMedix, Inc., headquartered in the United States, is a pioneering force in the radiopharmaceutical industry, specialising in the development and commercialisation of innovative diagnostic and therapeutic solutions. Founded in 2011, the company has made significant strides in advancing targeted radiotherapy, particularly in oncology, with a focus on improving patient outcomes. With a robust portfolio of unique products, including radiolabelled agents for imaging and treatment, RadioMedix stands out for its commitment to precision medicine. The company operates primarily in North America, with expanding influence in global markets. Recognised for its cutting-edge research and development, RadioMedix has established a strong market position, contributing to the evolution of personalised cancer care through its state-of-the-art technologies.
DitchCarbon Score
How does RadioMedix, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RadioMedix, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RadioMedix, Inc.'s reported carbon emissions
RadioMedix, Inc., headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company may still be engaged in broader industry efforts to address climate change, aligning with best practices in sustainability. As the landscape of corporate climate commitments evolves, it is essential for companies like RadioMedix to establish measurable targets and transparent reporting to contribute effectively to global emissions reduction goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
RadioMedix, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
